Denis Guttridge to Pancreatic Neoplasms
This is a "connection" page, showing publications Denis Guttridge has written about Pancreatic Neoplasms.
Connection Strength
1.996
-
Modeling Human Cancer-induced Cachexia. Cell Rep. 2019 08 06; 28(6):1612-1622.e4.
Score: 0.509
-
NF-?B regulates GDF-15 to suppress macrophage surveillance during early tumor development. J Clin Invest. 2017 Oct 02; 127(10):3796-3809.
Score: 0.446
-
NF-?B-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest. 2013 Nov; 123(11):4821-35.
Score: 0.341
-
STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer. Life Sci Alliance. 2022 11; 5(11).
Score: 0.156
-
Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer. Pancreatology. 2019 Jan; 19(1):80-87.
Score: 0.121
-
Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-na?ve pancreatic cancer patients. J Cachexia Sarcopenia Muscle. 2018 04; 9(2):358-368.
Score: 0.114
-
Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma. J Surg Oncol. 2018 May; 117(6):1260-1266.
Score: 0.113
-
Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions. Pancreas. 2017 10; 46(9):1152-1157.
Score: 0.112
-
Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease. Pancreas. 2013 Jul; 42(5):813-8.
Score: 0.083